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The fatty acyl composition of phospholipids deter-
mines the biophysical character of membranes and
impacts the function of membrane proteins. Here,
wedefine anuclear receptor pathway for the dynamic
modulation of membrane composition in response to
changes in cellular lipid metabolism. Ligand activa-
tion of liver X receptors (LXRs) preferentially drives
the incorporation of polyunsaturated fatty acids into
phospholipids through induction of the remodeling
enzyme Lpcat3. Promotion of Lpcat3 activity amelio-
rates endoplasmic reticulum (ER) stress induced by
saturated free fatty acids in vitro or by hepatic lipid
accumulation in vivo. Conversely, Lpcat3 knockdown
in liver exacerbates ER stress and inflammation.
Mechanistically, Lpcat3 modulates inflammation
both by regulating inflammatory kinase activation
through changes in membrane composition and by
affecting substrate availability for inflammatorymedi-
ator production. These results outline an endogenous
mechanism for thepreservationofmembranehomeo-
stasis during lipid stress and identify Lpcat3 as an
important mediator of LXR effects on metabolism.
INTRODUCTION
Phospholipids (PLs) are important components of biological
membranes and precursors of numerous signaling molecules.
PL membranes compartmentalize living cells, form intracellular
organelles, and provide platforms for a wide variety of physiolog-
ical processes, such as vesicle trafficking, signal transduction,
molecular transport, and biosynthesis. PLs also act as sub-
strates for the generation of diverse bioactivemolecules involved
in signal transduction, including eicosanoids, lysophosphatidicCell Macid (LPA), and diacylglycerol (Holzer et al., 2011; Spector and
Yorek, 1985).
The fatty acyl composition of PLs determines the biophysical
characteristics of membranes, including fluidity and the assem-
bly of specific membrane subdomains (Holzer et al., 2011;
Spector and Yorek, 1985). Therefore, changes in fatty acyl
composition can affect the properties of proteins associated
with membranes and influence the biological processes that
occur on them. Modification of the fatty acyl composition of
membranes influences a range of cell processes, most impor-
tantly the activity of membrane-bound enzymes and trans-
porters and the localization of acylated proteins in membrane
subdomains (Cornelius, 2001; Fu et al., 2011; Holzer et al.,
2011). For example, membrane fatty acyl composition affects
the activity of the Na+/K+-adenosine triphosphatase (ATPase)
and the sarcoplasmic-endoplasmic reticulum calcium ATPase-
2b (SERCA2b) (Cornelius, 2001; Li et al., 2004). It is also known
that incorporation of saturated fatty acids into plasma mem-
brane recruits c-Src kinase to lipid raft domains and increases
its activity (Holzer et al., 2011).
In mammalian cells, PLs are initially synthesized by the
de novo pathway and subsequently undergo remodeling through
fatty acyl deacylation and reacylation, a pathway referred to as
the Lands cycle (Lands, 1958). As a result, saturated fatty acids
are preferably linked at the sn-1 position and unsaturated fatty
acids at the sn-2 position. This diversity and asymmetric distribu-
tion is established largely by the remodeling process, as the de
novo PL synthesis process has little fatty acyl-coenzyme A
(CoA) substrate specificity. In the liver, a major enzyme that
catalyzes the formation of phosphatidylcholine (PC) from satu-
rated lysophosphatidylcholines (LysoPCS) and unsaturated fatty
acyl-CoAs is lysophosphatidylcholine acyltransferase 3 (Lpcat3)
(Hishikawa et al., 2008; Li et al., 2012; Zhao et al., 2008). Lpcat3
preferentially synthesizes PC containing unsaturated fatty acids,
particularly arachidonic acid (20:4) and linoleic acid (18:2), at the
sn-2 position.
To date, most studies of the effects of PL fatty acyl composi-
tion on biological systems have utilized in vitro biochemicaletabolism 18, 685–697, November 5, 2013 ª2013 Elsevier Inc. 685
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membrane composition in living cells. Therefore, there is little un-
derstanding of how regulatory pathways control PL fatty acyl
composition or how such regulatory pathways could dictate
cell responses. It is known that increased levels of saturated fatty
acids can cause ER stress, and this has been postulated to
involve changes in ER membrane composition (Borradaile
et al., 2006). It has also been shown that inhibition of SCD-1 or
Lpcat3 activity increases membrane saturation, secondary to
changes in fatty acid production (Miyazaki et al., 2000) or phos-
pholipid remodeling (Ariyama et al., 2010), respectively. Loss of
either SCD-1 or Lpcat3 activity has been shown to enhance ER
stress in cultured cells (Ariyama et al., 2010). But are there regu-
latory pathways that modify membrane lipid composition in
response to extracellular or intracellular cues? Furthermore,
could such pathways be targeted pharmacologically to manipu-
late ERmembrane composition? Finally, what is the contribution
of PL remodeling to ER stress responses in the setting of meta-
bolic disease?
The liver X receptors (LXRs) are important regulators of choles-
terol and fatty acid homeostasis and potent inhibitors of inflam-
mation (Hong and Tontonoz, 2008). However, the impact of LXRs
on phospholipids, the major constituents of membranes, has not
been rigorously investigated. Here, we show that LXRs are reg-
ulators of membrane phospholipid composition and that this
previously unappreciated action underlies the ability of LXRs to
influence ER stress and inflammation. Lpcat3, which encodes
a key enzyme in the PL remodeling pathway, is a direct LXR
target gene in mice and humans. LXR activation promotes the
incorporation of unsaturated fatty acids into PL through Lpcat3,
thereby reducing hepatic ER stress and inflammation in the
context of genetic obesity. These studies identify the LXR-
Lpcat3 pathway as an important modulator of PL metabolism,
metabolic stress responses, and inflammation.
RESULTS
Lpcat3 Is a Direct Target of LXR in Mice and Humans
We previously identified Lpcat3 (also known as MBOAT5) as an
LXR-responsive gene through transcriptional profiling studies of
BV-2 cells (Zelcer et al., 2007). Lpcat3 was also reported to be
responsive to synthetic LXR agonists in other cell lines (Demeure
et al., 2011). However, the dependence of Lpcat3 on the genetic
expression of LXRa and LXRb has not been examined. Lpcat3 is
widely expressed in mice, with especially prominent expression
in metabolic tissues (Figure S1A available online). Exposure of
primary mouse hepatocytes to the synthetic LXR agonists
GW3965 or T1317 induced the expression of Lpcat3 as well as
the established targets Idol andAbca1 (Figure 1A). The combina-
tion of LXR and retinoid X receptor (RXR) ligands further boosted
Lpcat3 expression (Figure 1B). Importantly, the ability of LXR
agonist to promote Lpcat3 expression was lost in Lxrab/ cells.
Furthermore, both LXRa and LXRb are competent to regulate
Lpcat3, as the response to ligands was comparable between
Lxra/ and Lxrb/ cells (Figures 1B and S1B). We also ob-
served regulation of Lpcat3 by LXR agonists in several other
cell types, including primary macrophages, RAW264.7 cells,
and Hep3B cells (Figures S1C, S1D, and S1G). Regulation of
Lpcat3 by LXR was not sensitive to cycloheximide, suggesting686 Cell Metabolism 18, 685–697, November 5, 2013 ª2013 Elsevierthat it was a direct transcriptional effect (Figure S1E). It was
also not secondary to the induction of sterol regulatory
element-binding protein 1c (SREBP-1c) because oxysterols
that block SREBP processing still induced Lpcat3 expression
(Figures S1F and S1G). Finally, administration of GW3965
(40 mg/kg/day) for 3 days to C57BL/6 mice induced the expres-
sion of Lpcat3 in multiple tissues, including liver, fat, muscle, and
kidney (Figures 1C and S1H).
Given the activity of Lpcat3, we reasoned that LXR activation
might regulate PL fatty acyl composition. Using an acyltransfer-
ase assay with radiolabeled fatty acyl-CoA and LysoPC, we
found that LXR agonist increased lysophosphatidylcholine acyl-
transferase activity and drove the formation of PC (Figure 1D).
Furthermore, electrospray ionization-tandem mass spectrom-
etry (ESI-MS/MS) analysis of whole-cell lipid extracts showed
that LXR ligand treatment markedly increased the abundance
of polyunsaturated PC, especially arachidonoyl (20:4)- and lino-
leoyl (18:2)-containing phosphatidylcholine (PC), in RAW 264.7
cells (Figure 1E). The abundance of monounsaturated PC and
saturated PC was not affected or even reduced (Figure 1E). On
the other hand, stable knockdown of Lpcat3 expression in
RAW 264.7 cells with shRNA constructs reduced Lpcat3 expres-
sion and activity (Figure S1I), as well as the amount of 20:4- and
18:2-containing PC (Figure 1F). The regulation of PL metabolism
by LXRwas also evident in vivo. Treatment of C57BL/6mice with
GW3965 for 2 days led to a change in the abundance of several
polyunsaturated PC species in total liver extracts (Figure 1G),
including those containing linoleic acid (18:2), one of the
preferred substrates of Lpcat3 (Hishikawa et al., 2008).
LXR Suppresses Saturated Fatty Acid-Induced
Endoplasmic Reticulum Stress
High levels of saturated fatty acids, such as palmitic acid (PA),
are postulated to trigger the ER stress pathway by altering mem-
brane dynamics and integrity (Borradaile et al., 2006). The obser-
vation that LXR increased levels of unsaturated PLs led us to
explore whether LXR was able to protect cells from saturated
fatty acid-induced ER stress. We first assessed the unfolded
protein response (UPR) signaling pathways activated by the
accumulation of unfolded proteins commonly used as indicators
of ER stress. Pretreatment of Hep3B hepatoma cells with
GW3965 blunted the induction of the downstream UPR target
genes C/EBP homology protein (CHOP) and activating transcrip-
tion factor 3 (ATF3) by PA in a dose-dependent manner (Figures
2A and S2A). Similar effects were observed in primary mouse
hepatocytes and macrophages (Figures S2B and S2C). Interest-
ingly, however, LXR ligand had no effect on the induction of ER
stress by thapsigargin (Figure 2A), suggesting that LXR specif-
ically modulates lipid-induced ER stress. The protective effects
of LXR agonist were observed in wild-type, but not in Lxrab/
primary hepatocytes, indicating that they are indeed mediated
by LXRs (Figure 2B). The absence of LXRs also sensitized hepa-
tocytes to PA-induced ER stress markers. In addition, LXR
agonist treatment decreased the formation of spliced Xbp1
mRNA and reduced the phosphorylation of protein kinase-like
ER kinase (PERK) and eukaryotic initiation factor 2a (EIF2a) (Fig-
ures 2C and 2D).
The accumulation of excess free cholesterol in macrophages
is also known to trigger the activation of ER stress pathwaysInc.
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Figure 1. LXRs Regulate Lpcat3 Expression and Activity
(A) Primary mouse hepatocytes were treated with GW3965 (GW, 1 mM) or T0901317 (T, 1 mM) overnight. Gene expression in this and all subsequent figures was
analyzed by real-time PCR. Results are representative of three independent experiments. Values are means ± SD.
(B) LXR-dependent regulation of Lpcat3 in primary mouse hepatocytes after overnight treatment with GW (1 mM) or T (1 mM) and/or the RXR ligand LG268
(LG, 50 nM). Results are representative of two independent experiments. Values are means ± SD.
(C) Induction of Lpcat3 mRNA expression in livers of mice treated with 40 mg/kg/day GW3956 by oral gavage for 3 days (n = 5 per group). Values are
means ± SEM.
(D) Stable RAW 264.7 LXRa cells were treated with the LXR agonist GW (1 mM). Microsomal Lpcat3 activity wasmeasured by radiolabeled acyltransferase assay.
Thin-layer chromatogram is shown (upper panel); radioactivity in excised bands was quantified by scintillation counter (lower left). Induction of Lpcat3mRNAwas
measured by real-time PCR (lower right). Results are representative of two independent experiments. Values are means ± SD.
(E) ESI-MS/MS analysis of the abundance of PC species in Raw 264.7 cells treated with GW3965 (1 mM) for 48 hr. n = 3 per group. Values are means ± SEM.
(F) ESI-MS/MS analysis of the abundance of PC species in Raw 264.6 cells stably expressing shRNA targeting Lpcat3 (shLpcat3) or LacZ (shCtrl). n = 3 per group.
Values are means ± SEM.
(G) ESI-MS/MS analysis of the abundance of PC species in livers fromC57BL/6mice treated with 20mg/kg GW3965 by oral gavage, 2 doses/day for 2 days (n = 5
per group). Values are means ± SEM.
Statistical analysis was performed using Student’s t test in (C), (E), (F), and (G). *p < 0.05; **p < 0.01. See also Figure S1.
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LXRs Promote Phospholipid Remodeling(Feng et al., 2003). Treatment of primary mouse macrophages
with LXR agonist blunted the induction of UPR target genes
induced by loading with acetylated low-density lipoprotein
(LDL) in the presence of an acyl-CoA acyltransferase (ACAT)
inhibitor (Figure 2E). Chronic ER stress induced by lipotoxicity
eventually causes cell apoptosis. Hep3B cells pretreated with
LXR ligand were protected from saturated fatty acid-induced
apoptosis, as assessed by caspase-3 activity (Figures S2D
and S2E).Cell MLpcat3 Contributes to LXR-Dependent Suppression of
ER Stress Signaling
Next, we addressed the mechanism by which LXR protects cells
from lipid-induced ER stress. Prior biochemical studies have
shown that unsaturated PLs increase membrane dynamics,
an effect that might potentially reverse deleterious effects of
saturated fatty acids on membrane structure. We therefore
hypothesized that LXRs might reduce ER stress by increasing
the proportion of polyunsaturated PLs in membranes throughetabolism 18, 685–697, November 5, 2013 ª2013 Elsevier Inc. 687
Figure 2. LXRs and Lpcat3 Attenuate Lipid-Induced ER Stress
(A) Hep3B cells were pretreatedwith GW3965 (1 mM) for 24 hr, followed by stimulationwith BSA-conjugated palmitic acid (PA), BSA-conjugated oleic acid (OA), or
thapsigargin (Tg) at the indicated concentration for 6 hr. Induction of CHOP and ATF3 mRNA was analyzed by real-time PCR. Values are means ± SD.
(B) Primary hepatocytes from wild-type and LXRab/mice were pretreated with GW3965 (1 mM) for 24 hr and then stimulated with 500 mMBSA-conjugated PA.
Values are means ± SD.
(C) Hep3B cells were pretreated with GW3965 (GW, 1 mM) for 24 hr, followed by stimulation with BSA-conjugated PA. Induction of Xbp-1 splicing was analyzed by
PCR and gel electrophoresis.
(D) Hep3B cells were pretreated with GW3965 (1 mM) for 24 hr and stimulated with BSA-conjugated PA at the indicated concentrations. Activation of UPR
signaling was analyzed by immunoblotting.
(E) Concanavalin A-elicited peritoneal macrophages were treated with GW3965 (1 mM) and loaded with cholesterol by incubation with acetylated LDL (ac-LDL)
alone or acylated LDL and ACAT inhibitor to induce ER stress. Values are means ± SD.
(F) Hep3B cells were transfected with siRNA targeting Lpcat3 (siLpcat3) or scramble (siCtrl) for 48 hr, followed by stimulation with BSA-conjugated PA. Values are
means ± SD.
(G) Hep3B cells were transfected as in (F). Phosphorylation of eIF2a was analyzed by immunoblot. t-EIF2a, total EIF2a; p-EIF2a, phospho-EIF2a.
Statistical analysis was by two-way ANOVA with Bonferroni post hoc tests in (A), (B), (E), and (F). *p < 0.05; **p < 0.01; n.s., not significant. See also Figure S2.
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down of Lpcat3 decreased membrane PL unsaturation (Fig-
ure 1F), loss of Lpcat3 also affected fatty acid-induced ER
stress. siRNA-mediated knockdown of Lpcat3 in Hep3B cells
markedly enhanced the expression of CHOP and ATF3 (Fig-
ure 2F), as well as the phosphorylation of eIF2a in response to
PA (Figure 2G).
To address whether Lpcat3 activity mediated protective
effects of LXR on ER stress, we treated primary hepatocytes
with LXR agonist in the presence or absence of Lpcat3 knock-
down. LXR agonist strongly suppressed the expression of
sXBP-1, ATF3, and ATF-4 in response to PA (Figure 3A). The
magnitude of suppression by LXR agonist was reduced, but688 Cell Metabolism 18, 685–697, November 5, 2013 ª2013 Elseviernot abolished, by shRNA-mediated knockdown of Lpcat3. The
residual effect of LXR agonist on ER stress is consistent with
prior studies showing that SCD-1 also inhibits ER stress (Erbay
et al., 2009).
To establish that the effects of LXR on cellular PL composition
were dependent on Lpcat3, we examined primary mouse hepa-
tocytes deficient in either LXR or Lpcat3 expression. Treatment
of wild-type hepatocytes with GW3965 increased the abun-
dance of PC species containing 20:4 or 18:2 acyl chains, and
this effect was completely abrogated in hepatocytes from mice
lacking both LXRa and LXRb (DKO; Figure 3B). Furthermore,
shRNA-mediated knockdown of Lpcat3 expression in primary
hepatocytes blunted the ability of LXR agonist to induce levelsInc.
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Figure 3. Lpcat3 Contributes to LXR-Dependent PL Remodeling and ER Stress Reduction
(A) Primarymouse hepatocytes were transfectedwith adenoviral shRNA targeting Lpcat3 (shLpcat3) or control (shCtrl) for 48 hr, with GW3965 (1 mM) treatment for
the last 24 hr, followed by stimulation with 500 mM BSA-conjugated PA. Gene expression was analyzed by real-time PCR. The percent of repression of PA-
induced gene expression by GW is indicated for control versus Lpcat3 knockdown. Values are means ± SEM.
(B) ESI-MS/MS analysis of the abundance of PC species in primary hepatocytes from wild-type or LXRab/ (DKO) mice treated with GW3965 (1 mM) for 48 hr.
n = 3 per group. Values are means ± SEM.
(C) ESI-MS/MS analysis of the abundance of PC species in wild-type primary hepatocytes transfected with adenoviral shRNA targeting Lpcat3 (shLpcat3) or
control (shCtrl) for 48 hr and treated with GW3965 (1 mM) for the last 24 hr. n = 3 per group. Values are means ± SEM.
(D) Hep3B cells were treated with increasing concentrations of liposomes composed of different species of PC, followed by stimulation with BSA-conjugated PA
at 500 mM. Values are means ± SD.
(E) Hep3B cells were treated with vehicle or 1 mM bromoenol lactone (BEL) and then incubated with liposomes made with 16:0 20:4 PC or vehicle (veh). BSA-
conjugated PA (500 mM) was used to stimulated ER stress. Values are means ± SD.
Statistical analysis was by Student’s t test (A) (over the percent of repression in shCtrl), one-way ANOVA with Bonferroni post hoc tests (D), or two-way ANOVA
with Bonferroni post hoc tests (B) (C) (E). *p < 0.05; **p < 0.01; n.s., not significant.
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LXRs Promote Phospholipid Remodelingof these same unsaturated PC species (Figure 3C). Thus, the
ability of GW3965 to modulate cellular PL composition is depen-
dent on both LXR and Lpcat3 expression.
The primary function of Lpcat3 is to catalyze the formation of
polyunsaturated PL. Therefore, we reasoned that polyunsatu-
rated PLs produced by Lpcat3 are the bioactive molecules that
mediate the effects of the LXR pathway on ER stress. If this
hypothesis is correct, then treatment of cells with arachido-
noyl-containing PC should mimic the protective effects. Indeed,
pretreatment of cells with liposomes made with 16:0, 20:4 PC,
but not saturated 16:0, 18:0 PC, inhibited PA-induced ER stressCell Min a dose-dependent manner (Figure 3D). Since polyunsaturated
fatty acids are known to reduce ER stress, we considered the
possibility that the protective effects of arachidonoyl-containing
PC were secondary to the enzymatic release of arachidonic acid
from the PC. To rule out this possibility, we used the phospholi-
pase A2 inhibitor bromoenol lactone (BEL), to prevent the release
of arachidonic acid.We found that 16:0, 20:4 PC retained its pro-
tective effects even in the presence of BEL treatment (Figure 3E),
strongly suggesting that the arachidonoyl-containing PC itself is
the active molecule. In sum, these results demonstrate that LXR
activation protects cells from lipid-induced ER stress, at least inetabolism 18, 685–697, November 5, 2013 ª2013 Elsevier Inc. 689
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Figure 4. Inhibition of the LXR-Lpcat3 Pathway Increases ER Stress In Vivo
(A) Wild-type and Lxrab/ (DKO) mice were fed aWestern diet for 12 weeks. Liver gene expression was analyzed by real-time PCR. n = 4–5 per group. Values are
means ± SEM.
(B) ob/obmice were transduced with adenoviral-expressed shRNA targeting Lpcat3 (shLpcat3) or control (shCtrl) for 7 days. UPR signaling in livers was analyzed
by real-time PCR on day 7, normalized to GAPDH, and shown as fold change over shCtrl. n = 6 per group. Values are means ± SEM.
(C) Immunoblot analysis of protein expression in livers of ob/ob mice transduced with adenoviral shCtrl or shLpcat3 for 7 days.
(D) ESI-MS/MS analysis of liver PC species from ob/obmice transduced with adenoviral shCtrl or shLpcat3 for 7 days. n = 6 per group. Values are means ± SEM.
Statistical analysis was performed using Student’s t test. *p < 0.05; **p < 0.01. See also Figure S3.
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LXRs Promote Phospholipid Remodelingpart, by promoting the Lpcat3-mediated formation of unsatu-
rated PC species.
The LXR-Lpcat3 Pathway Regulates Metabolic ER
Stress In Vivo
ER stress has been observed in a number of metabolic dis-
eases and is postulated to be a key pathogenic factor in their
development. Therefore, we investigated the physiological
impact of the LXR-Lpcat3 pathway on ER stress in mouse
models of metabolic disease. To test whether endogenous
LXR signaling influenced the development of hepatic ER stress
induced by a lipid-rich diet, we fed Lxrab/ (DKO) mice and
wild-type littermates a Western diet for 12 weeks. DKO mice
exhibited increased expression of ER stress markers, including
ATF3 and CHOP (Figure 4A). Furthermore, increased ER stress
pathway activation correlated with reduced Lpcat3 expression
in the livers of DKO mice (Figure 4A). To address whether
Lpcat3 deficiency would exacerbate metabolic ER stress
in vivo, we used adenoviral vectors to deliver a shRNA con-
struct targeting Lpcat3 to the livers of ob/ob mice—a genetic
model of obesity known to exhibit hepatic ER stress (Ozcan
et al., 2004). shRNA-mediated knockdown of Lpcat3 induced
the expression of a panel of genes linked to ER stress
(sXBP1, CHOP, ATF3, BIP; Figure 4B) compared to shRNA
control. This was also accompanied by increased phosphoryla-
tion of PERK and eIF2a (Figure 4C), consistent with enhanced
ER stress pathway activation.690 Cell Metabolism 18, 685–697, November 5, 2013 ª2013 ElsevierSince the ability of Lpcat3 to ameliorate ER stress in vitro
correlated with production of unsaturated PC (Figures 1 and 2),
we analyzed the effect of Lpcat3 expression on PL fatty acyl
composition in vivo. ESI-MS/MS analysis of total lipids revealed
clear changes in PC fatty acyl composition in mouse liver trans-
ducedwith shLpcat3 adenovirus compared to control, and these
changes were largely consistent with our results in cultured cells.
The amount of arachidonoyl- and linoloyl-containing PC species
was reduced by shRNA-mediated knockdown of Lpcat3, while
the amounts of saturated or monounsaturated PC were not
changed or even increased by Lpcat3 knockdown (Figure 4D).
Similar trends were observed for PE fatty acyl composition, in
line with prior reports that PE is also a substrate for Lpcat3-
dependent remodeling (Figure S3A).
After 7 days of transduction with shLpcat3, ob/ob mice
exhibited a modest decrease in blood glucose levels and no
significant change in plasma insulin, suggesting that there was
minimal effect on the insulin resistance phenotype over this
time frame (Figure S3B). Plasma triglyceride (TG) levels were
modestly increased, and liver TG levels were decreased (Fig-
ure S3B). These observations are consistent with prior reports
that Lpcat3 and ER stress affect VLDL secretion from the liver
(Li et al., 2012; Wang et al., 2012).
We transduced adenoviral vectors expressing EGFP control or
Lpcat3 into ob/obmice to ask whether increased Lpcat3 activity
in the liver might ameliorate lipid-induced ER stress. Adenoviral
expression of Lpcat3 in ob/ob livers reduced expression ofInc.
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Figure 5. Expression of Lpcat3 in Mouse Liver Affects Metabolism and Reduces ER Stress
(A) ob/obmice were transduced with adenovirus expressing Lpcat3 (Ad-Lpcat3) or control EGFP (Ad-Ctrl) for 7 days. Liver gene expression was determined by
real-time PCR, normalized to 36B4, and presented as fold change over Ad-Ctrl. n = 6 per group. Values are means ± SEM.
(B) Metabolic parameters in ob/ob mice transduced with Ad-Ctrl or Ad-Lpcat3 for 7 days. n = 6 per group. Values are means ± SEM.
(C) Glucose tolerance test performed on ob/ob mice transduced with Ad-Ctrl or Ad-Lpcat3 4 days after infection. n = 6 per group. Values are means ± SEM.
(D) db/dbmice were transducedwith Ad-Ctrl or Ad-Lpcat3 for 7 days. Gene expressionwas determined by real-time PCR, normalized to 36B4, and shown as fold
change over Ad-Ctrl. n = 5 per group. Values are means ± SEM.
Statistical analysis was performed using Student’s t test compared to control. *p < 0.05; **p < 0.01.
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LXRs Promote Phospholipid RemodelingATF3, and there was a trend toward decreased spliced XBP-1
(Figure 5A). Interestingly, Lpcat3 expression in this model was
also associated with an improvement in glucose homeostasis.
Mice expressing Lpcat3 had reduced blood glucose levels,
plasma insulin levels, and insulin resistance index compared to
control-transduced mice (Figure 5B). There was no difference
in liver or plasma TG levels or plasma free fatty acids. Lpcat3-
transduced ob/ob mice also showed modest improvement in
glucose tolerance compared to controls (Figure 5C).
We employed db/db mice as an additional model of lipid-
induced hepatic ER stress. Thesemice exhibit more severe insu-
lin resistance, hepatic steatosis, and inflammation comparedCell Mto ob/ob mice. Expression of Lpcat3 in db/db mice reduced
the expression of ER stress-associated genes, including
CHOP, ATF3, and sXBP-1 (Figure 5D). Collectively, these data
implicate the LXR-Lpcat3 pathway as a physiological regu-
lator of PL fatty acyl composition in mouse liver that affects
hepatic UPR signaling in the setting of metabolic stress.
Although we observed relatively modest changes in lipid and
glucose metabolism in response to Lpcat3-dependent pertur-
bations in ER stress over the 7-day time frame of these
studies, we cannot exclude the possibility that more chronic
changes in Lpcat3 activity might have more robust metabolic
effects.etabolism 18, 685–697, November 5, 2013 ª2013 Elsevier Inc. 691
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Figure 6. Lpcat3 Activity Modulates Hepatic Inflammation In Vivo
(A) Immunostaining with F4/80 antibody of liver sections fromC57BL/6mice transducedwith adenoviral-expressed shRNA targeting Lpcat3 (shLpcat3) or control
(shCtrl) for 8 days.
(B) C57BL/6 mice were transduced with adenovirus-expressed shLpcat3 or shCtrl. Gene expression in livers was analyzed by Affymetrix arrays after 8 days.
Select inflammatory genes are presented by heatmap. n = 5 per group.
(C) Gene expression of livers from ob/obmice transduced with shLpcat3 or shCtrl for 7 days. Results were normalized to 36B4 and are presented as fold change
over shCtrl. n = 6 per group. Values are means ± SEM.
(D) Gene expression of livers fromC57BL/6mice transducedwith adenoviral-expressed Lpcat3 (Ad-Lpcat3) or control EGFP (Ad-GFP) for 9 days. n = 6 per group.
Results were normalized to 36B4 and are presented as fold change over Ad-GFP. Values are means ± SEM.
(E) Gene expression of livers from ob/ob mice transduced with Ad-Lpcat3 or Ad-GFP for 7 days. n = 6 per group. Results were normalized to 36B4 and are
presented as fold change over Ad-GFP. Values are means ± SEM. Statistical analysis was by Student’s t test. *p < 0.05; **p < 0.01. See also Figure S4.
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In Vivo
Since alteration of membrane lipid composition has been shown
to affect inflammatory signaling, we further investigated the influ-
ence of Lpcat3 activity on hepatic inflammation. Histological
analysis of livers from wild-type C57BL/6 mice transduced with
shLpcat3 adenovirus revealed marked infiltration of F4/80+
macrophages, consistent with ongoing inflammation (Figure 6A).
Macrophage infiltration in Lpcat3 knockdown livers was con-
firmed by analysis of F4/80 gene expression (Figure S4A).
Furthermore, expression of proinflammatory cytokines (mono-
cyte chemoattractant protein 1 [MCP-1], tumor necrosis factor692 Cell Metabolism 18, 685–697, November 5, 2013 ª2013 Elsevieralpha [TNF-a], and interleukin 1b [IL-1b]) was elevated in
shLpcat3-transduced livers compared to controls, indicative of
enhanced inflammatory signaling (Figure S4B). To comprehen-
sively analyze the impact of Lpcat3 knockdown on hepatic
gene expression, we performed transcriptional profiling. This
analysis revealed that a large number of proinflammatory genes
were induced in response to Lpcat3 knockdown, including
proinflammatory cytokines and chemokines, cytokine and che-
mokine receptors, and complement components (Figure 6B).
Next, we investigated whether Lpcat3 activity could also
modulate hepatic inflammatory responses in the setting of meta-
bolic disease and hepatic steatosis. Indeed, knockdown ofInc.
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LXRs Promote Phospholipid RemodelingLpcat3 expression with an adenoviral shRNA vector in ob/ob
mouse liver exacerbated the expression of a panel of proinflam-
matory cytokines and chemokines, including Cox-2, MCP-1, and
MIP-2 (Figure 6C). Consistent with increased hepatic inflamma-
tion, plasma alanine aminotransferase (ALT) and aspartate
aminotransferase (AST) levels were also increased (Figure S4C).
We further tested the effect of increased Lpcat3 activity on
hepatic inflammatory signaling in both wild-type and genetically
obese mice. Adenovirus-mediated Lpcat3 expression in wild-
type livers reduced the basal expression of a panel of inflamma-
tory cytokines (Figure 6D). In fact, many of the same genes
increased by Lpcat3 knockdown were reduced by Lpcat3
expression. Interestingly, we did not observe any difference in
ER stress markers in wild-typemice overexpressing Lpcat3 (Fig-
ure S4D), suggesting that the effects of Lpcat3 on inflammation
may be independent of ER stress.We also employed ob/obmice
as a model of lipid-induced hepatic inflammation. Remarkably,
expression of Lpcat3 in livers of these mice ameliorated inflam-
mation, evidenced by a marked reduction in the expression of
inflammatory chemokines and cytokines (Figure 6E). Similar re-
sults on inflammatory markers and plasma AST and ALT levels
were also observed in db/dbmice (Figures S4E and S4F). These
data suggest that Lpcat3 is a regulator of hepatic inflammation
and that enhanced Lpcat3 activity has beneficial effects on
inflammation in the setting of metabolic disease.
Lpcat3 Activity Affects the Production of Lipid
Inflammatory Mediators
To address whether the effects of Lpcat3 activity on inflamma-
tion were cell autonomous, we analyzed inflammatory signaling
in cultured primary hepatocytes and macrophages. shRNA-
mediated knockdown of Lpcat3 in primary mouse hepatocytes
with an adenoviral vector led to increased expression of well-
established hepatic inflammatory mediators, including CXCL10
and MIP-2 (Figure 7A). Furthermore, knockdown of Lpcat3
ameliorated the suppressive effect of LXR agonist on the
expression of these genes. Similarly, siRNA-mediated knock-
down of Lpcat3 expression in murine peritoneal macrophages
augmented the induction of inflammatory genes in response
to lipopolysaccharide (LPS) (Figure S5A). Lpcat3 knockdown
in macrophages blunted the ability of LXR agonist to
repress MCP-1 and, to a lesser extent, TNF-a expression. This
observation suggests that Lpcat3 induction by LXR may con-
tribute to the repressive effects of LXR agonists on some inflam-
matory genes.
Products of arachidonic acid and lysoPCs are well-known
proinflammatory lipid mediators (Funk, 2001; Kabarowski,
2009). Since activation of the LXR-Lpcat3 pathway converts
the bioactive free arachidonic acid and lysoPCs into PLs, we
hypothesized that increased activity of this pathway may limit
inflammatory mediator production by limiting substrate availabil-
ity. In support of this idea, acute induction of Lpcat3 activity by
treatment with LXR agonist (GW3965) strongly reduced the
levels of multiple LysoPC species (Figure 7B). This effect was
completely abolished by Lpcat3 knockdown. Although we did
not observe changes in lysoPC levels between shCtrl- and
shLpcat3-treated WT mice after 8 days, this may reflect
compensatory responses in LysoPC metabolism in the setting
of chronic alteration of Lpcat3 activity. Furthermore, gasCell Mchromatography-mass spectrometry (GC-MS) analysis revealed
greatly increased levels of free arachidonic acid in livers of wild-
type mice in which Lpcat3 expression was knocked down (Fig-
ure 7C). Conversely, ectopic expression of Lpcat3 in livers of
wild-type mice markedly decreased levels of free arachidonate
(Figure 7D). We also analyzed prostaglandin E2 (PGE2) produc-
tion by LPS-stimulated macrophages in vitro. Consistent with
our hypothesis that Lpcat3 activity limits arachidonic acid avail-
ability for eicosanoid synthesis, ligand activation of LXR in these
cells repressed PGE2 secretion (Figure S5B). Collectively, these
findings suggest that Lpcat3 activity affects inflammation, at
least in part, through modulation of lipid inflammatory mediator
production.
Lpcat3 ActivityModulates c-SrcActivation inMembrane
Microdomains
Increasing membrane saturation has been shown to affect the
compartmentalization and activity of membrane-bound c-Src
kinase by recruiting the protein to membrane microdomains,
sometimes referred to as lipid rafts (Holzer et al., 2011). Activated
c-Src initiates the downstream JNK signaling pathway, a central
regulator of inflammation (Wellen and Hotamisligil, 2005). Given
that activation of Lpcat3 reduces membrane saturation, we
hypothesized that the LXR-Lpcat3 pathway might regulate the
activity of the c-Src-JNK pathway through modulation of mem-
brane lipid composition. In support of this idea, treatment of pri-
mary macrophages with LXR agonist decreased LPS-stimulated
phosphorylation of membrane-bound c-Src kinase (Figure 7E).
Induction of ABCA1 served as a positive control for LXR activa-
tion. On the contrary, knockdown of Lpcat3 expression with an
adenoviral shRNA vector in ob/ob mouse liver increased the
phosphorylation of c-Src and JNK (Figure 7F). To examine
whether Lpcat3 activity altered the compartmentalization and
activation of c-Src in membrane microdomains, Hep3B cells
were treated with Lpcat3 siRNA followed by PA stimulation.
Detergent-resistant membrane (DRM) was isolated through
density gradient centrifugation. DRM and its associated proteins
were enriched in fraction 2, as indicated by flotillin 1 (Flot1),
while soluble protein and cell debris were enriched in fractions
3 and 4, as shown by transferrin receptor (TfR), a membrane
protein excluded from detergent-resistant membranes (DRMs).
In Lpcat3 knockdown cells, phospho-c-Src abundance was
greatly increased in the DRM fraction, although the amount of
total c-Src protein in DRM was unchanged (Figure 7G). This
observation strongly suggests that a reduction in the abundance
of Lpcat3 PL products alters the structure of membrane micro-
domains in a way that favors the activation of c-Src. Thus, in
addition to modulation of lipid inflammatory mediators, Lpcat3
activity also regulates the activation of the c-Src-JNK pathway.
Collectively, our results define mechanisms whereby LXR sig-
naling modulates ER and inflammatory homeostasis in response
to changing cellular lipid levels through Lpcat3.
DISCUSSION
Given the difficulty of manipulating fatty acyl composition in
living cells, few studies have addressed the physiological impact
of dynamic changes in PL fatty acyl composition. We have
shown here that LXR regulates PL fatty acyl composition throughetabolism 18, 685–697, November 5, 2013 ª2013 Elsevier Inc. 693
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Figure 7. Lpcat3 Activity Controls Lipid Mediator Availability and c-Src Activation
(A) Primary hepatocytes were transduced with adenoviral-expressed shLpcat3 or shCtrl at a multiplicity of infection (moi) of 10 for 60 hr and treated with vehicle
or GW3965 for 24 hr, followed by PA stimulation. Gene expression was analyzed by real-time PCR, normalized to 36B4, and shown as fold change over
veh + DMSO + shctrl. Values are means ± SD.
(B) ESI-MS/MS analysis of lysophosphatidylcholine species in the livers from C57BL/6 mice transduced with shLpcat3 or shCtrl for 8 days and gavaged with
GW3965 at 40 mg/kg body weight once per day on days 6, 7, and 8. n = 5 per group. Values are means ± SEM.
(C) GC-MS analysis of free fatty acid species in the livers from C57BL/6 mice transduced with shLpcat3 or shCtrl for 8 days. Results are presented as the percent
of total free fatty acid.
(D) GC-MS analysis of free fatty acid species in the livers from C57BL/6 mice transduced with Ad-Lpcat3 or Ad-EGFP. n = 6 per group. Results are presented as
the percent of of total free fatty acid.
(E) Primary mouse macrophages were treated with GW3965 (1 mM) and stimulated with 10 ng/ml LPS. Cellular membranes were isolated by ultracentrifugation
and analyzed by immunoblotting.
(F) Immunoblot analysis of livers from ob/ob mice transduced with adenoviral shLpcat3 or shCtrl for 7 days.
(G) Hep3B cells were transfected with adenoviral shLpcat3 or shCtrl for 48 hr, followed by stimulation with 500 mM BSA-conjugated PA. Detergent-resistant
membranes were isolated by gradient centrifugation and analyzed by immunoblotting.
Statistical analysis was by Student’s t test (B) (C) (D) or two-way ANOVAwith Bonferroni post hoc tests (A). For (B), Student’s t test was performed between vehicle
and GW3965 treatment in each subgroup. *p < 0.05; **p < 0.01. See also Figure S5.
Cell Metabolism
LXRs Promote Phospholipid Remodelingregulation of Lpcat3. Induction of Lpcat3 by LXR promotes the
formation of polyunsaturated PLs and decreases membrane
saturation. This membrane remodeling counteracts saturated
fatty acid-induced ER stress in hepatocytes and mouse liver.
Furthermore, the LXR-Lpcat3 pathway ameliorates hepatic
inflammation by modulating c-Src kinase activation and control-
ling the availability of lipid inflammatory mediators. These obser-
vations identify Lpcat3 regulation as an important mechanism by
which LXR signaling modulates lipid homeostasis in both physi-
ology and disease.694 Cell Metabolism 18, 685–697, November 5, 2013 ª2013 ElsevierStudies of in vitro biochemical systems have demonstrated
that changes in PL fatty acyl composition strongly affect mem-
brane protein function. Whether membrane fatty acyl composi-
tion is actively regulated by endogenous signaling pathways
has not been intensively studied. The SREBP pathway is an
important determinant of membrane lipid composition due to
its regulation of cholesterol and PL synthesis (Brown and Gold-
stein, 1999). Our study has identified the LXR-Lpcat3 pathway
as a physiological regulator of membrane fatty acyl composition.
This function fits well with LXRs’ previously defined roles asInc.
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LXRs Promote Phospholipid Remodelingcoordinators of cholesterol and fatty acid metabolism. The fatty
acyl chain of polyunsaturated PL assumes a flexible and bent
conformation, resulting in decreased membrane order and
increased membrane fluidity. Notably, cellular levels of choles-
terol, another important membrane structural component, are
also regulated by LXR signaling. Activation of LXRs reduces
cholesterol levels by promoting cholesterol efflux and inhibiting
cholesterol uptake (Calkin and Tontonoz, 2012), an effect that
would be expected to impact membrane order and fluidity.
LXR is also an important regulator of SCD-1 expression (Chu
et al., 2006; Repa et al., 2000). Increased desaturation of newly
synthesized fatty acids increases substrate availability for
synthesis of unsaturated PC. Indeed, increased SCD-1 expres-
sion has been proposed to alleviate ER stress in atherosclerosis
(Erbay et al., 2009). Thus, LXR signaling alters membrane lipid
composition and modifies membrane physical properties
through multiple mechanisms.
ER stress is observed in livers of obese mice and humans and
has been postulated to be a contributor to metabolic disease.
We observed modest changes in systemic metabolism in
response to short-term alterations in Lpcat3 activity. In partic-
ular, adenoviral expression of Lpcat3 in the livers of ob/ob
mice lowered blood glucose and insulin levels. However, more
chronic models (e.g., transgenics or knockouts) are likely better
suited to test the ability of Lpcat3 to affect the development or
progression of metabolic disease.
The exact mechanisms by which obesity activates ER stress
are incompletely understood, but saturated free fatty acids are
believed to alter ER membrane structure (Borradaile et al.,
2006; Volmer et al., 2013). Excess saturated fatty acids are
rapidly incorporated into PLs in ER membranes, resulting in
increased membrane order and reduced membrane fluidity.
Although the nature of the link between membrane fluidity and
ER stress is not yet clear, a growing body of evidence suggests
that altered lipid composition affects the function of ER mem-
brane proteins. For instance, enrichment of ER membrane with
saturated PLs in vitro inhibits the activity of the calcium pump
SERCA2b (Li et al., 2004), leading to ER Ca2+ depletion and
the activation of ER stress. Recently, increased ER membrane
saturation has been shown to enhance the activation of IRE1a
and PERK directly (Volmer et al., 2013). Our results support a
biophysical model in which the LXR-Lpcat3 pathway alters
membrane fatty acyl composition and fluidity, thereby counter-
acting the membrane-toxic effects of saturated fatty acid and
alleviating ER stress.
Activated LXRs strongly suppress the expression of proinflam-
matory cytokines and chemokines in response to inflammatory
stimuli (Hong and Tontonoz, 2008). However, the precise mech-
anisms underlying LXR’s anti-inflammatory effects are not clear.
In this study, we have shown that Lpcat3, a direct transcriptional
target of LXR, strongly modulates inflammatory responses
in vitro and in vivo. Knockdown of Lpcat3 in mouse liver induced
a series of inflammatory responses, including macrophage
infiltration, increased serum ASL and ALT, and upregulation of
proinflammatory cytokines and chemokines. Conversely, over-
expression of Lpcat3 hadopposite effects, indicating that Lpcat3
enzyme activity is a potent modifier of inflammatory responses.
How does Lpcat3-mediated modulation of PL composition
influence inflammatory responses in hepatocytes? JNK is aCell Mproinflammatory kinase whose downstream signaling cascade
controls various inflammatory responses (Solinas et al., 2007;
Tuncman et al., 2006). Recently, Holzer et al. (2011) reported
that changes in membrane lipid composition affect JNK activa-
tion by altering the compartmentalization and activation of
c-Src kinase in cell membranes. Treatment of cells with PA in-
creases the partitioning and activation of c-Src in membrane
subdomains with higher order and rigidity, which in turn phos-
phorylates JNK and initiates the JNK signaling cascade. We
found that knockdown of Lpcat3, which reduces membrane
fluidity, also increased the activation of c-Src and JNK in livers
of obese mice. Moreover, knockdown of Lpcat3 in hepatocytes
enhanced the activation of c-Src in DRMs in response to PA
stimulation, directly implicating c-Src and JNK signaling in the in-
flammatory effects of Lpcat3. These data suggest that modula-
tion ofmembrane lipid composition is a keymechanismbywhich
Lpcat3 activity affects inflammatory signaling in hepatocytes.
In addition to affecting membrane physical properties, modu-
lation of Lpcat3 activity alters the availability of the two sub-
strates in the enzymatic reaction, LysoPC and free arachidonic
acid, both of which have been demonstrated to be involved in
inflammatory responses. The reduction in LysoPC and arachi-
donic acid availability may be an additional mechanism by which
Lpcat3 activity influences inflammatory signaling. However,
further studies are needed to elucidate the precise signaling
pathways that connect LysoPC and arachidonic acid with
hepatic inflammatory responses. Recently, another study re-
ported that the LXR-Lpcat3 pathway also regulates PL meta-
bolism in human primary macrophages (Ishibashi et al., 2013).
However, in contrast to our work, that study suggested that
LXR ligands stimulate eicosanoid secretion and proinflammatory
effects. Such effects are difficult to reconcile with the large body
of literature supporting the net anti-inflammatory actions of
endogenous LXR signaling in vitro and in vivo (Hong and Tonto-
noz, 2008). We find LXR signaling to be strongly anti-inflamma-
tory in macrophages, although synthetic LXR agonists can exert
nonspecific inflammatory effects in some contexts.
Abnormal cellular membrane lipid composition and fluidity
have been observed in several metabolic diseases. For example,
cellular membranes from atherosclerotic and obese individuals
show decreased fluidity (Faloia et al., 1999). Although direct
in vivo evidence is still needed to establish the pathogenic
effects of abnormal membrane lipid composition, multiple
in vitro studies have demonstrated that alterations in membrane
lipid composition affect cellular ion balance, inflammation, and
ER stress, all of which are involved in the development of chronic
metabolic diseases. Our data indicate that increased Lpcat3
activity is able to modulate membrane lipid composition,
increase membrane fluidity, and, most importantly, reduce
inflammation and ER stress in liver. These findings suggest
that regulation of PL remodeling might represent a strategy for
intervention in chronic metabolic diseases.EXPERIMENTAL PROCEDURES
Reagents and Plasmids
LXR ligands GW3965 and T0901317 were synthesized according to published
methods (Collins et al., 2002a; Collins et al., 2002b; Li et al., 2000). Thapsigar-
gin and oxysterols were from Sigma. Sequences of shRNA targeting mouseetabolism 18, 685–697, November 5, 2013 ª2013 Elsevier Inc. 695
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LXRs Promote Phospholipid RemodelingLpcat3 were designed using BLOCK-iT RNAi Designer tool (Invitrogen).
Sense and antisense oligos were annealed and cloned into pENTR/U6 vector
using the BLOCK-iT U6 RNAi Entry Vector Kit (Invitrogen). The shRNA con-
structs were further cloned into gateway-adapted pBabe-puro plasmids
through LR recombination (Invitrogen). The following shRNA oligos were
used: lacZ shRNA CACCGGGCCAGCTGTATAGACATCTCGAAAGATGTCTA
TACAGCTGGCCC and Lpcat3 shRNA CACCGCAGGTCAGCAGTCTAA
TTCGTTCAAGAGACGAATTAGACTGCTGACCTGC. Only sense strands are
shown. Ad-Lpcat3 and Ad-shLpcat3 adenoviral vectors were generated
by LR recombination of pEntr-Lpcat3 or pEntr/U6-shLpcat3 and pAd/CMV/
V5-DEST (Invitrogen). Viruses were amplified, purified, and titered by
ViraQuest Inc.
Cell Culture
Human embryonic kidney 293T (HEK293T), HEK293A, Huh7, and Raw264.7
cells were cultured in Dulbecco’s modified Eagle’s medium (DMEM) with
10% fetal bovine serum (FBS) and antibiotics at 37C and 5% CO2. Hep3B
cells were cultured in Eagle’s minimal essential medium (EMEM). Mouse
primary hepatocytes were isolated from 2- to 3-month-old male C57BL/6
mice, Lxra/, Lxrb/, or Lxrab/ mice and cultured in William’s E
medium with 5% FBS. Bone marrow-derived macrophages and thioglycol-
late-elicited or concanavalin A-elicited peritoneal macrophages were isolated
as described (Castrillo et al., 2003; Feng et al., 2003). Raw 264.7 stable cell
lines were made by pBabe retroviral vectors as described (Venkateswaran
et al., 2000).
Gene Expression and Microarray Analysis
Total RNA was isolated with TRIzol (Invitrogen). cDNA was synthesized
with the iScript cDNA synthesis kit (Bio-Rad) and quantified by real-time
PCR using SYBR Green (Diagenode) on an Applied Biosystems 7900
instrument. Gene expression levels were determined by using a standard
curve. Each gene was normalized to 36B4 or glyceraldehyde-3-phosphate
dehydrogenase (GAPDH). Primer sequences are available upon request. For
microarray experiments, liver tissues were harvested 8 days after adenovirus
injection. RNA was pooled from n R 5 biological replicates and processed
in the UCLA Microarray Core Facility using GeneChip Mouse Gene 430.2
Arrays (Affymetrix). Data analysis was performed using GeneSpringGX soft-
ware (Agilent).
Animal Studies
Male C57BL/6, ob/ob, and db/db mice (8–12 weeks old) were acquired from
Jackson Laboratory. Lxra/, Lxrb/, and Lxrab/ mice were originally
from David Mangelsdorf. Mice were fed a standard chow diet and housed in
a temperature-controlled environment under a 12 hr light-dark cycle under
pathogen-free conditions. For adenoviral infections, 8- to 10-week-old male
mice were injected with 2 3 109 or 3 3 109 plaque-forming units (pfu) by the
tail vein. Mice were sacrificed 7–9 days later following a 6 hr fast. Fasting blood
glucose was measured before sacrifice. Liver tissues were collected and
immediately frozen in liquid nitrogen and stored at 80C or fixed in 10%
formalin. Blood was collected by direct cardiac puncture with plasma sepa-
rated by centrifugation. ALT and AST were determined at the UCLA core facil-
ity. Plasma lipids were measured using Wako L-Type TG M kit and Wako HR
series NEFA-HR(2) kit. Liver triglycerides were extracted using Bligh-Dyer lipid
extraction (Bligh and Dyer, 1959) and measured by Wako L-Type TG M kit.
Animal experiments were conducted in accordance with the UCLA Animal
Research Committee.
Statistical Analysis
Statistics were performed using Student’s t test (two groups) or ANOVA
(greater than two groups), with post hoc tests to compare to the control group.
Data are presented asmeans ± SEM ormeans ± SD, as indicated, and consid-
ered statistically significant at p < 0.05.
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